|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Cascadian Therapeutics, Inc (CASC) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
50,560,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$10.02 - $10.02 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Florence Anthony A. Jr. |
10% Owner |
– – • |
2018-02-20 |
4 |
OE |
$3.30 |
$5,999,400 |
I/I |
1,818,000 |
10,882,574 |
|
- |
|
| Viswanathan Ravi |
10% Owner |
– – • |
2018-02-20 |
4 |
OE |
$3.30 |
$5,999,400 |
I/I |
1,818,000 |
10,882,574 |
|
- |
|
| Sandell Scott D |
10% Owner |
– – • |
2018-02-20 |
4 |
OE |
$3.30 |
$5,999,400 |
I/I |
1,818,000 |
10,882,574 |
|
- |
|
| Barris Peter J |
10% Owner |
– – • |
2018-02-20 |
4 |
OE |
$3.30 |
$5,999,400 |
I/I |
1,818,000 |
10,882,574 |
|
- |
|
| Baskett Forest |
10% Owner |
– – • |
2018-02-20 |
4 |
OE |
$3.30 |
$5,999,400 |
I/I |
1,818,000 |
10,882,574 |
|
- |
|
| Myers Scott Dunseth |
President and CEO |
• • – |
2018-01-11 |
4 |
D |
$3.92 |
$13,442 |
D/D |
(3,429) |
56,787 |
|
- |
|
| Myers Scott Dunseth |
President and CEO |
• • – |
2018-01-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,500 |
60,216 |
|
- |
|
| Christianson Gary |
Chief Operating Officer |
• – – |
2018-01-11 |
4 |
D |
$3.92 |
$3,618 |
D/D |
(923) |
6,515 |
|
- |
|
| Christianson Gary |
Chief Operating Officer |
• – – |
2018-01-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,825 |
7,438 |
|
- |
|
| Peterson Scott Robert |
Chief Scientific Officer |
• – – |
2018-01-11 |
4 |
D |
$3.92 |
$3,618 |
D/D |
(923) |
3,639 |
|
- |
|
| Peterson Scott Robert |
Chief Scientific Officer |
• – – |
2018-01-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,825 |
4,562 |
|
- |
|
| Eastland Julia Marie |
CFO & CBO |
• – – |
2018-01-11 |
4 |
D |
$3.92 |
$3,618 |
D/D |
(923) |
5,237 |
|
- |
|
| Eastland Julia Marie |
CFO & CBO |
• – – |
2018-01-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,825 |
6,160 |
|
- |
|
| Walker Luke Nathaniel |
SVP, Clinical Development |
• – – |
2018-01-11 |
4 |
D |
$3.92 |
$2,497 |
D/D |
(637) |
5,303 |
|
- |
|
| Walker Luke Nathaniel |
SVP, Clinical Development |
• – – |
2018-01-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,950 |
5,940 |
|
- |
|
| Spiegelman Daniel K |
Director |
– • – |
2017-09-24 |
4 |
D |
$3.94 |
$2,340 |
D/D |
(594) |
21,006 |
|
- |
|
| Spiegelman Daniel K |
Director |
– • – |
2017-09-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,375 |
21,600 |
|
- |
|
| Love Ted W |
Director |
– • – |
2017-09-24 |
4 |
D |
$3.94 |
$2,340 |
D/D |
(594) |
37,394 |
|
- |
|
| Love Ted W |
Director |
– • – |
2017-09-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,375 |
37,988 |
|
- |
|
| James Steven P |
Director |
– • – |
2017-09-24 |
4 |
D |
$3.94 |
$2,340 |
D/D |
(594) |
13,677 |
|
- |
|
| James Steven P |
Director |
– • – |
2017-09-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,375 |
14,271 |
|
- |
|
| Henney Christopher S |
Director |
– • – |
2017-09-24 |
4 |
D |
$3.94 |
$2,340 |
D/D |
(594) |
60,185 |
|
- |
|
| Henney Christopher S |
Director |
– • – |
2017-09-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,375 |
60,779 |
|
- |
|
| Myers Scott Dunseth |
President and CEO |
• • – |
2017-08-11 |
4 |
B |
$3.74 |
$20,543 |
D/D |
5,500 |
49,716 |
2.81 |
- |
|
| Love Ted W |
Director |
– • – |
2017-06-24 |
4 |
D |
$3.78 |
$8,562 |
D/D |
(2,265) |
35,613 |
|
- |
|
221 Records found
|
|
Page 2 of 9 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
